| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2001;103:2539.)
© 2001 American Heart Association, Inc.
Special Report |
Percutaneous In Situ Coronary Venous Arterialization
Report of the First Human Catheter-Based Coronary Artery Bypass
From Massachusetts General Hospital, Harvard Medical School, Boston, Mass (S.N.O.); Kardiologisches Institut, Bad Soden, Germany (N.R.); Krankenhaus der Barmherzigen Brüder, Trier, Germany (E.H.); Toyohashi Heart Center, Toyohashi, Japan (M.H.); and Stanford University Medical Center, Stanford, Calif (A.C.Y.).
Correspondence to Stephen N. Oesterle, MD, Director, Invasive Cardiology Services, Massachusetts General Hospital, Bulfinch 105, 55 Fruit Street, Boston, MA 02114. E-mail Oesterle.Stephen{at}mgh.harvard.edu
Abstract—Diffuse coronary artery disease is frequently untreatable by coronary artery bypass or angioplasty. Many such "no-option" patients have been subjects for trials of angiogenesis using growth factor manipulation or laser injury. We think these novel revascularization strategies are limited by insufficient inflow to putative areas of new microvasculature and thus seek a more mechanical solution. We report the use of a catheter-based system for arterializing the adjacent anterior cardiac vein in a patient with chronic total occlusion of the left anterior descending coronary artery. A composite catheter system (phased-array ultrasound imaging system mounted on a catheter with extendable nitinol needle) was used to deliver an exchange-length intracoronary guidewire from the proximal left anterior descending coronary artery into the parallel anterior interventricular vein. Using standard angioplasty techniques, a fistula was then constructed from the proximal artery to the coronary vein using a self-expanding connector. The proximal vein was blocked with a novel self-expanding "blocker," thus precluding "steal" through the coronary sinus and forcing retroperfusion of the anterior wall. The procedure was completed without complication, and a follow-up angiogram at 3 months confirmed continued patency of the arteriovenous connection. This patient, who had severe angina before the procedure, has been asymptomatic for 12 months. Percutaneous in situ venous arterialization may be an effective therapy for diffuse, "untreatable" coronary disease by supplying a robust inflow of arterialized blood via retroperfusion to severely ischemic myocardium.
This article has been cited by other articles:
 |
|
 |
|
  G. S. Kassab, J. A. Navia, K. March, and J. S. Choy Coronary venous retroperfusion: an old concept, a new approach J Appl Physiol, May 1, 2008; 104(5): 1266 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Resetar, C. Ullmann, P. Broeske, K. Ludwig-Schindler, N. K. Doll, A. Salameh, S. Dhein, and F. W. Mohr Selective arterialization of a cardiac vein in a model of cardiac microangiopathy and macroangiopathy in sheep J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1252 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Jaumdally, C. Varma, R. J. Macfadyen, and G. Y.H. Lip Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment? Eur. Heart J., April 2, 2007; 28(8): 929 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Stone, N. J. Reifart, I. Moussa, A. Hoye, D. A. Cox, A. Colombo, D. S. Baim, P. S. Teirstein, B. H. Strauss, M. Selmon, et al. Percutaneous Recanalization of Chronically Occluded Coronary Arteries: A Consensus Document: Part II Circulation, October 18, 2005; 112(16): 2530 - 2537. [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Singh, S. Houser, E. K. Heist, and J. N. Ruskin The Coronary Venous Anatomy: A Segmental Approach to Aid Cardiac Resynchronization Therapy J. Am. Coll. Cardiol., July 5, 2005; 46(1): 68 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Raake, R. Hinkel, C. Kupatt, M.-L. v. Bruhl, S. Beller, M. Andrees, C. Vicol, and P. Boekstegers Percutaneous approach to a stent-based ventricle to coronary vein bypass (venous VPASSTM): comparison to catheter-based selective pressure-regulated retro-infusion of the coronary vein Eur. Heart J., June 2, 2005; 26(12): 1228 - 1234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pappone, F. Manguso, G. Vicedomini, F. Gugliotta, O. Santinelli, A. Ferro, S. Gulletta, S. Sala, N. Sora, G. Paglino, et al. Prevention of Iatrogenic Atrial Tachycardia After Ablation of Atrial Fibrillation: A Prospective Randomized Study Comparing Circumferential Pulmonary Vein Ablation With a Modified Approach Circulation, November 9, 2004; 110(19): 3036 - 3042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.e. E. Mesas, C. Pappone, C. C.E. Lang, F. Gugliotta, T. Tomita, G. Vicedomini, S. Sala, G. Paglino, S. Gulletta, A. Ferro, et al. Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: Electroanatomic characterization and treatment J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1071 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.W Serruys and J Aoki Therapeutic options for patients with chronic myocardial ischaemia Eur. Heart J. Suppl., September 1, 2004; 6(suppl_E): E2 - E11. [Abstract] [Full Text]
|
|
|
|
|
|
I. D. Cox, C. A. Thompson, and S. N. Oesterle Biointerventional cardiovascular therapy Eur. Heart J., November 2, 2002; 23(22): 1753 - 1756. [Full Text] [PDF]
|
|
|
|
 |
|
 C. A Thompson and S. N Oesterle Biointerventional cardiology: the future interface of interventional cardiovascular medicine and bioengineering Vascular Medicine, May 1, 2002; 7(2): 135 - 140. [Abstract] [PDF]
|
|
|
|
|
|
M. C. Kim, A. Kini, and S. K. Sharma Refractory angina pectoris: Mechanism and therapeutic options J. Am. Coll. Cardiol., March 20, 2002; 39(6): 923 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Percutaneous In Situ Coronary Venous Arterialization Journal Watch Cardiology, July 6, 2001; 2001(706): 3 - 3. [Full Text]
|
|